# Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Natalie Staplin,Richard Haynes,PK Judge,Christoph Wanner,Julie Green,Jonathan Emberson,David Preiss,KJ Mayne,SYA Ng,Emily Sammons,Dandan Zhu,Michael Hill,W. Grant Stevens,Karl Wallendszus,S Brenner,AK Cheung,Zhihong Liu,J Li,LS Hooi,Wenjun Liu,Takashi Kadowaki,Masaomi Nangaku,Adeera Levin,David Z.I. Cherney,Aldo P. Maggioni,Roberto Pontremoli,Rajat Deo,Shinichi Goto,Xavier Rosselló,Katherine R. Tuttle,Dominik Steubl,Michaela Petrini,Siegfried Seidi,Martin Landray,Colin Baigent,WG Herrington,Sharirose Abat,Riaz Rahman,Rizna Abdul Cader,MI Abdul Hafidz,MZ Abdul Wahab,NK Abdullah,Talal Abdulsamad,Masami Abe,Ned Abraham,Sarah Acheampong,P Achiri,JA Acosta,A A Adeleke,Vicki Adell,R Adewuyi-Dalton,Nihad Adnan,A Africano,Mohsen Agharazii,Frank G. Aguilar,A Aguilera,M Ahmad,MK Ahmad,NA Ahmad,NH Ahmad,NI Ahmad,Norazinizah Ahmad Miswan,H Ahmad Rosdi,Iffat Ahmed,Sofia B. Ahmed,Sofia B. Ahmed,Joan Aiello,Alastair Aitken,R AitSadi,Sendogan Aker,S Akimoto,Akinwande A. Akinfolarin,S. Akram,Federico Alberici,Christian Albert,Luke Aldrich,M Alegata,Lacy M. Alexander,S Alfaress,Mohammad Alhadj Ali,A Ali,A Ali,Radica Z. Alicic,Arta Aliu,Ricardo López Almaraz,Rashid Almasarwah,Jussara Carnevale de Almeida,Alessia Aloisi,Laith Al‐Rabadi,Mark Dominik Alscher,Pedro Álvarez,Bader Al-Zeer,M. Ochoa de Olza Amat,Christopher S. Ambrose,Hany Ammar,Yu An,L Andriaccio,K Ansu,A Apostolidi,N. Arai |
| Citations | 94 |
| DOI | 10.1016/s2213-8587(23)00321-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thelancet.com/article/S2213858723003212/pdf |
| OpenAlex ID | https://openalex.org/W4389296028 |
| PMID | 38061371 |
| Type | article |
| Year | 2023 |

## Paper authors

Showing 10 of 17.

- [Dominik Steubl](https://scholariq.org/researchers/dominik-steubl/)
- [Christoph Wanner](https://scholariq.org/researchers/christoph-wanner/)
- [Takashi Kadowaki](https://scholariq.org/researchers/takashi-kadowaki/)
- [Aldo P. Maggioni](https://scholariq.org/researchers/aldo-p-maggioni/)
- [Masaomi Nangaku](https://scholariq.org/researchers/masaomi-nangaku/)
- [Adeera Levin](https://scholariq.org/researchers/adeera-levin/)
- [Claire C. Sharpe](https://scholariq.org/researchers/claire-c-sharpe/)
- [Ankeet S. Bhatt](https://scholariq.org/researchers/ankeet-s-bhatt/)
- [Jonathan J. Taliercio](https://scholariq.org/researchers/jonathan-j-taliercio/)
- [Kentaro Watanabe](https://scholariq.org/researchers/kentaro-watanabe/)

## Paper funders

Showing 8 of 31.

- [American Heart Association](https://scholariq.org/funders/american-heart-association/)
- [American Society of Nephrology](https://scholariq.org/funders/american-society-of-nephrology/)
- [Amgen](https://scholariq.org/funders/amgen/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Sanofi](https://scholariq.org/funders/sanofi/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.